Navigation Links
Simbionix Takes Non-Invasive GYN Surgical Training to the Next Level

CLEVELAND, Ohio, June 2 /PRNewswire/ -- Simbionix has announced the release of a new and exciting module for its LAP Mentor simulator that gives trainees hands-on experience with different techniques and alternative approaches to the treatment of ectopic pregnancy, tubal sterilization and oophorectomy.

The GYN module is the latest addition to the suite of laparoscopic procedures developed for the LAP Mentor, the world's most advanced laparoscopic surgery simulator. The GYN module makes full use of the LAP Mentor's 3-D real-life graphics and ergonomically designed hardware to provide the most realistic experience of training and learning possible.

The module includes an expandable library of virtual patients with a variety of anatomical anomalies and complications, a complete set of laparoscopic instruments including those unique to GYN procedures, exceptional audio and visual learning aids and a comprehensive set of performance metrics.

In announcing the release of the new module, Simbionix President Ran Bronstein commented: "This demonstrates Simbionix continued commitment to our LAP customers. We are committed to continuous on going development that will keep the LAP Mentor the most advanced laparoscopic system on the market. Our goal is to assure customers unsurpassed value and maximum benefits from their purchase of Simbionix Simulators".

About Simbionix USA Corporation

Simbionix is the industry leader in the development of innovative and effective medical simulation products used for clinical education and training of medical professionals. Simbionix products are designed to accelerate best-practice medical training, advance clinical performance and improve patient safety. The company is committed to continuously innovating and broadening its product offerings with a wide range of training modules, case studies and scenarios, developed in response to the growing importance of clinical training and education as a means of achieving improved patient care.
Additional company information can be found at


Inbal Mazor

VP Marketing

Tel: +972-8-9211177

SOURCE Simbionix
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. 2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators
2. Migenix Takes Operational Actions To Extend Cash Past Upcoming Key Milestones
3. Board Certified Dermatologist and President-Elect of the Dermatologic Society of Greater New York, Dr. Lance H. Brown Takes His Comprehensive Practice to East Hampton, NY
4. Tepper School Team Takes Top Honors at Global Moot Corp(R) Competition
5. Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic
6. White Paper Advises Pharma Manufacturers on How to Select an Aseptic Fill/Finish Contractor, Avoid the Most Common Mistakes
7. Ground-Breaking Conference Takes on Abortion
8. First European IGRT School Takes Place for Radiotherapy Practitioners in UK
9. N.C. Takes Biofuels Leadership, Establishes New Endeavor With $5 Million State Appropriation
10. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
11. InSightec Resumes Clinical Trials for Non-Invasive Treatment of Brain Tumors
Post Your Comments:
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... Pleasant Prairie, WI (PRWEB) , ... June 23, ... ... sciences consultancy focused on quality, regulatory and technical consulting, provides a free ... webinar is presented on July 13, 2016 at 12pm CT at no charge. ...
Breaking Biology Technology:
(Date:6/15/2016)... June 15, 2016 Transparency ... titled "Gesture Recognition Market by Application Market - Global Industry Analysis ... 2024". According to the report, the  global gesture recognition ... 2015 and is estimated to grow at a ... by 2024.  Increasing application of gesture ...
(Date:6/2/2016)... 2016 The Department of Transport Management ... 44 million US Dollar project, for the , ... Personalization, Enrolment, and IT Infrastructure , to ... and implementation of Identity Management Solutions. Numerous renowned international vendors ... Decatur was selected for the most compliant and ...
(Date:5/20/2016)... 2016  VoiceIt is excited to announce its ... By working together, VoiceIt and VoicePass will ... VoicePass take slightly different approaches to voice biometrics, ... and usability. ... partnership. "This marketing and technology partnership ...
Breaking Biology News(10 mins):